Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures

被引:213
作者
Caviedes, L
Lee, TS
Gilman, RH
Sheen, P
Spellman, E
Lee, EH
Berg, DE
Montenegro-James, S
机构
[1] Johns Hopkins Univ, Sch Publ Hlth & Hyg, Dept Int Hlth, Baltimore, MD 21205 USA
[2] Univ Peruana Cayetano Heredia, Dept Pathol, Lima, Peru
[3] Asoc Benefica Proyectos Informat Salud Med & Agr, Lima, Peru
[4] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA
[5] Washington Univ, St Louis, MO 63110 USA
[6] Alton Ochsner Med Fdn & Ochsner Clin, New Orleans, LA 70121 USA
关键词
D O I
10.1128/JCM.38.3.1203-1208.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Inexpensive, rapid, and reliable methods of detecting infection by and drug susceptibility of Mycobacterium tuberculosis (MTB) are crucial to the control of tuberculosis. The novel microscopic observation broth-drug susceptibility assay (MODS) detects early growth of MTB in liquid medium, allowing more timely diagnosis and drug susceptibility testing. Sputum samples from hospitalized patients in Peru were analyzed by using stains, culture, and PCR. Sensitivity of MODS (92%) compared favorably with the most sensitive of the other culture methods (93%). Sputum samples positive for tuberculosis were tested for susceptibility to isoniazid and rifampin with the microwell alamar blue assay (MABA) and MODS. In 89% of cases, there was concordance between MODS and MABA. Of the diagnostic and susceptibility testing methods used, MODS yielded results most rapidly (median, 9.0 and 9.5 days, respectively). MODS is a rapid, inexpensive, sensitive, and specific method for MTB detection and susceptibility testing; it is particularly appropriate for use in developing countries burdened by significant infection rates and increasing numbers of multiple-drug-resistant cases.
引用
收藏
页码:1203 / 1208
页数:6
相关论文
共 28 条
[1]  
CHENG AF, 1994, J TROP MED HYG, V97, P249
[2]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[3]   Comparison of the amplified Mycobacterium tuberculosis (MTB) direct test, Amplicor MTB PCR, and IS6110-PCR for detection of MTB in respiratory specimens [J].
Dalovisio, JR ;
MontenegroJames, S ;
Kemmerly, SA ;
Genre, CF ;
Chambers, R ;
Greer, D ;
Pankey, GA ;
Failla, DM ;
Haydel, KG ;
Hutchinson, L ;
Lindley, MF ;
Nunez, BM ;
Praba, A ;
Eisenach, KD ;
Cooper, ES .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :1099-1106
[4]   TUBERCULOSIS-CONTROL IN RESOURCE-POOR COUNTRIES - ALTERNATIVE APPROACHES IN THE ERA OF HIV [J].
DECOCK, KM ;
WILKINSON, D .
LANCET, 1995, 346 (8976) :675-677
[5]  
Enarson DA., 1994, TUBERCULOSIS GUIDE L
[6]  
FAZAL N, 1992, FEMS MICROBIOL IMMUN, V105, P355, DOI 10.1016/0378-1097(92)90102-T
[7]   Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay [J].
Franzblau, SG ;
Witzig, RS ;
McLaughlin, JC ;
Torres, P ;
Madico, G ;
Hernandez, A ;
Degnan, MT ;
Cook, MB ;
Quenzer, VK ;
Ferguson, RM ;
Gilman, RH .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (02) :362-366
[8]   RAPID DETECTION OF TUBERCULOUS AND NONTUBERCULOUS MYCOBACTERIA BY MICROSCOPIC OBSERVATION OF GROWTH ON MIDDLEBROOK 7H11 AGAR [J].
IDIGORAS, P ;
PEREZTRALLERO, E ;
ALCORTA, M ;
GUTIERREZ, C ;
MUNOZBAROJA, I .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1995, 14 (01) :6-10
[9]  
KENT BD, 1985, PUBLIC HLTH MYCOBACT, P36
[10]   DETECTION OF MYCOBACTERIUM-TUBERCULOSIS IN PERIPHERAL-BLOOD [J].
KOLK, AHJ ;
KOX, LFF ;
KUIJPER, S ;
RICHTER, C .
LANCET, 1994, 344 (8923) :694-694